299 related articles for article (PubMed ID: 7823942)
21. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.
Schwarz JK; Devoto SH; Smith EJ; Chellappan SP; Jakoi L; Nevins JR
EMBO J; 1993 Mar; 12(3):1013-20. PubMed ID: 8458319
[TBL] [Abstract][Full Text] [Related]
22. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
[TBL] [Abstract][Full Text] [Related]
23. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
24. The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex.
Obert S; O'Connor RJ; Schmid S; Hearing P
Mol Cell Biol; 1994 Feb; 14(2):1333-46. PubMed ID: 8289811
[TBL] [Abstract][Full Text] [Related]
25. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
Whitaker LL; Su H; Baskaran R; Knudsen ES; Wang JY
Mol Cell Biol; 1998 Jul; 18(7):4032-42. PubMed ID: 9632788
[TBL] [Abstract][Full Text] [Related]
26. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
[TBL] [Abstract][Full Text] [Related]
27. Subunit composition determines E2F DNA-binding site specificity.
Tao Y; Kassatly RF; Cress WD; Horowitz JM
Mol Cell Biol; 1997 Dec; 17(12):6994-7007. PubMed ID: 9372931
[TBL] [Abstract][Full Text] [Related]
28. E2F-mediated growth regulation requires transcription factor cooperation.
van Ginkel PR; Hsiao KM; Schjerven H; Farnham PJ
J Biol Chem; 1997 Jul; 272(29):18367-74. PubMed ID: 9218478
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
30. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter.
Poma EE; Kowalik TF; Zhu L; Sinclair JH; Huang ES
J Virol; 1996 Nov; 70(11):7867-77. PubMed ID: 8892909
[TBL] [Abstract][Full Text] [Related]
31. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4.
Cress WD; Johnson DG; Nevins JR
Mol Cell Biol; 1993 Oct; 13(10):6314-25. PubMed ID: 8413230
[TBL] [Abstract][Full Text] [Related]
32. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
Arroyo M; Raychaudhuri P
Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
[TBL] [Abstract][Full Text] [Related]
33. Regulation of E2F1 activity by acetylation.
Martínez-Balbás MA; Bauer UM; Nielsen SJ; Brehm A; Kouzarides T
EMBO J; 2000 Feb; 19(4):662-71. PubMed ID: 10675335
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.
Almasan A; Yin Y; Kelly RE; Lee EY; Bradley A; Li W; Bertino JR; Wahl GM
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5436-40. PubMed ID: 7777526
[TBL] [Abstract][Full Text] [Related]
35. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
36. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
[TBL] [Abstract][Full Text] [Related]
37. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
Nakajima Y
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
[TBL] [Abstract][Full Text] [Related]
38. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.
Müller H; Moroni MC; Vigo E; Petersen BO; Bartek J; Helin K
Mol Cell Biol; 1997 Sep; 17(9):5508-20. PubMed ID: 9271426
[TBL] [Abstract][Full Text] [Related]
39. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.
Shan B; Durfee T; Lee WH
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):679-84. PubMed ID: 8570615
[TBL] [Abstract][Full Text] [Related]
40. Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest.
Knudsen KE; Fribourg AF; Strobeck MW; Blanchard JM; Knudsen ES
J Biol Chem; 1999 Sep; 274(39):27632-41. PubMed ID: 10488103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
